Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.

Breast cancer survivors Cancer prevention guidelines Health behaviors Health-related quality of life WCRF/AICR recommendations

Journal

The journal of nutrition, health & aging
ISSN: 1760-4788
Titre abrégé: J Nutr Health Aging
Pays: France
ID NLM: 100893366

Informations de publication

Date de publication:
05 Jul 2024
Historique:
received: 08 03 2024
revised: 26 06 2024
accepted: 27 06 2024
medline: 7 7 2024
pubmed: 7 7 2024
entrez: 6 7 2024
Statut: aheadofprint

Résumé

Adherence to healthy lifestyle recommendations has been reported to improve health-related quality of life (HRQL) in breast cancer (BC) patients, but the influence of long-term behavioral changes remains unknown. We evaluated the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations and HRQL both, at BC diagnosis and the change 7-12 years later. Prospective cohort study. A total of 406 breast cancer survivors, from the EpiGEICAM study, were recruited in 16 Spanish hospitals. Epidemiological, clinical, dietary, physical activity and HRQL information was collected both at recruitment and 7-12 years later. A 7-item score to measure compliance with recommendations was assessed according to the 2018 WCRF/AICR scoring criteria. HRQL was evaluated using SF-36 questionnaire. Linear mixed models for longitudinal data were used to assess the cross-sectional and longitudinal association between adherence score and the physical and mental component summary scores. At diagnosis, for each unit increase in WCRF/AICR score adherence, the HRQL physical domain increased 0.78 points (95%CI: -0.04 to 1.60; P trend:0.06). The mean change in physical HRQL from diagnosis to follow-up per unit increase in within-subject adherence score was 0.73 points (95%CI: -0.18 to 1.65; P trend: 0.12). For the mental domain, no association was observed with compliance with the recommendations at diagnosis, nor with changes in adherence over time. Our results suggest that Increased adherence to WCRF/AICR cancer prevention recommendations over time could contribute to slightly improved long-term physical HRQoL in BC survivors.

Identifiants

pubmed: 38970849
pii: S1279-7707(24)00399-3
doi: 10.1016/j.jnha.2024.100312
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100312

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Virginia Lope (V)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain. Electronic address: vicarvajal@isciii.es.

Ángel Guerrero-Zotano (Á)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Instituto Valenciano de Oncología, Valencia, Spain.

Nerea Fernández de Larrea-Baz (N)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Silvia Antolín (S)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Complejo Hospitalario de La Coruña (CHUAC), La Coruña, Spain.

Marta Benavent Viñuales (M)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Begoña Bermejo (B)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Clínico de Valencia, Biomedical Research Institut INCLIVA, Medicine Department, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.

Emma Ruiz-Moreno (E)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain.

José Manuel Baena-Cañada (JM)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain.

Lorena París (L)

Centro Oncológico de Galicia, La Coruña, Spain.

Antonio Antón (A)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Miguel Servet, Instituto Investigación Sanitaria Aragon, Departamento Medicina Universidad de Zaragoza, Zaragoza, Spain.

José Ignacio Chacón (JI)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Toledo, Toledo, Spain.

Montserrat Muñoz (M)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clinic i Provincial de Barcelona, FRCB-Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Department of Medicine, University of Barcelona, Barcelona, Spain.

José Angel García-Sáenz (JA)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Clara Olier (C)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital de Alcorcón, Madrid, Spain.

Pedro Sánchez Rovira (P)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Jaén, Jaén, Spain.

Angels Arcusa Lanza (A)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Consorci Sanitari de Terrassa, Barcelona, Spain.

Sonia González (S)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Mutua Terrassa, Barcelona, Spain.

Joan Brunet (J)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Institut Català d'Oncologia, Hospital Josep Trueta, Oncogir, IDIBGI, Girona, Spain.

Amparo Oltra (A)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Virgen de los Lirios, Alicante, Spain.

Susana Bezares (S)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Libertad Rosell (L)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Beatriz Pérez-Gómez (B)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Roberto Pastor-Barriuso (R)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain.

Miguel Martín (M)

GEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.

Marina Pollán (M)

Unidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Classifications MeSH